摘要
肺炎支原体是小儿社区获得性肺炎的重要病原体,其感染以年长儿童为高发人群,不仅有呼吸道症状,常又有肺外损害的特征。血清学检测是诊断肺炎支原体感染的标准实验室手段,但PCR方法对于免疫损坏及年幼患儿肺炎支原体感染早期诊断更加适合,并且其应用前景也更加广阔。大环内酯类抗生素是小儿肺炎支原体感染的首选抗生素,但如何进行标准化治疗现今仍未达成共识。本文针对以上内容进行了概述。
Mycoplasma pneumoniae is an important pathogen of community-acquired pneumonia in children. It is characterized not only by the high incidence of respiratory symptoms in elderly children but also often by extra-pulmonary injuries. Serological testing is the standard laboratory method for the diagnosis of M. pneumoniae infection. However, PCR method is more applicable for younger and immunocompromised children with M. pneumonia infection, and its application prospect is broader. Macrolide antibiotics are the first choice in antibiotic treatment for children with M.pneumonia infection, but how to carry out standardized treatment still reaches no consensus. This article has reviewed the current progress of diagnosis and treatment in children with Mycoplasma pneumoniae infection.
出处
《海南医学》
CAS
2016年第9期1486-1488,共3页
Hainan Medical Journal
关键词
肺炎支原体
儿童
诊断
治疗
Mycoplasma pneumoniae
Childhood
Diagnosis
Treatment
